Hye Yeon Chon

Bile Acids: Major Regulator of the Gut Microbiome

Chihyeok An, Hye Yeon Chon, Wanrim Ku et al. · Microorganisms · 2022 · 45 citations · Full text

Life Sciences, Microbiology, Pharmacology +10

Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patients

Hye Yeon Chon, Sang Hoon Ahn, Yoon Jun Kim et al. · Hepatology International · 2021 · 26 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Addition of liver stiffness enhances the predictive accuracy of the PAGE‐B model for hepatitis B‐related hepatocellular carcinoma

Hye Yeon Chon, Han Ah Lee, Sang Jun Suh et al. · Alimentary Pharmacology & Therapeutics · 2021 · 17 citations · Full text

Medicine, Internal Medicine, Oncology +17

Predictive Performance of CAGE-B and SAGE-B Models in Asian Treatment-Naive Patients Who Started Entecavir for Chronic Hepatitis B

Hye Yeon Chon, Jae Seung Lee, Hye Won Lee et al. · Clinical Gastroenterology and Hepatology · 2021 · 16 citations · Full text

Pharmacy, Biostatistics, Pharmacology +15

Association Between Handgrip Strength and Cardiovascular Disease Risk in MASLD: A Prospective Study From UK Biobank

Tae Seop Lim, Sujin Kwon, Sung A. Bae et al. · Journal of Cachexia Sarcopenia and Muscle · 2025 · 15 citations · Full text

Medicine, Internal Medicine, Exercise Testing +16